secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001628280-23-036843
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes receives FDA clearance for t:slim X2 pump and Control-IQ for children 2+
--------------------------------------------------------------------------------

- FDA cleared 510(k) applications for t:slim X2 insulin pump and Control-IQ technology enhancements on Nov 3, 2023.
- Expanded pediatric indication now includes individuals two years of age and older.
- This clearance broadens the eligible patient population for Tandem's automated insulin delivery system.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000162828023036843/0001628280-23-036843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000162828023036843/tndm-20231103.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-036843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer